NPI: 1043224355 · BROOKLYN, NY 11203 · Internal Medicine Physician · NPI assigned 07/29/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 07/29/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 79,041 | $710K |
| 2019 | 197,002 | $7.42M |
| 2020 | 545,511 | $27.85M |
| 2021 | 916,848 | $41.59M |
| 2022 | 811,880 | $40.91M |
| 2023 | 650,888 | $32.72M |
| 2024 | 585,809 | $27.66M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 176,759 | 152,550 | $15.64M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 98,891 | 91,765 | $15.25M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 73,970 | 68,592 | $11.77M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 93,367 | 83,373 | $10.18M |
| 90791 | Psychiatric diagnostic evaluation | 13,842 | 12,300 | $9.64M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 103,613 | 88,593 | $6.96M |
| 90832 | Psychotherapy, 30 minutes with patient | 46,972 | 31,515 | $6.50M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 160,952 | 20,567 | $6.24M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 33,871 | 32,364 | $5.77M |
| G0378 | Hospital observation service, per hour | 3,223 | 3,180 | $3.71M |
| S9485 | Crisis intervention mental health services, per diem | 3,125 | 2,560 | $3.53M |
| 90834 | Psychotherapy, 45 minutes with patient | 15,788 | 10,045 | $3.04M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 34,574 | 30,466 | $2.42M |
| 36415 | Collection of venous blood by venipuncture | 233,164 | 148,626 | $2.20M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12,583 | 12,310 | $2.12M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 16,115 | 15,751 | $1.98M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,985 | 9,641 | $1.98M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 113,271 | 96,687 | $1.97M |
| 99215 | Prolong outpt/office vis | 12,305 | 11,645 | $1.87M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 10,310 | 1,447 | $1.85M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 38,773 | 24,850 | $1.81M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,659 | 10,225 | $1.65M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 25,296 | 22,220 | $1.50M |
| D0999 | Unspecified diagnostic procedure, by report | 9,318 | 9,011 | $1.49M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 16,553 | 14,698 | $1.36M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 12,506 | 11,550 | $1.32M |
| D9999 | Unspecified adjunctive procedure, by report | 8,244 | 7,748 | $1.18M |
| 99205 | Prolong outpt/office vis | 5,194 | 5,034 | $1.10M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 22,589 | 22,352 | $1.09M |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,430 | 9,822 | $1.08M |
| 80053 | Comprehensive metabolic panel | 94,475 | 87,796 | $1.06M |
| 99442 | 19,907 | 18,120 | $997K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 46,307 | 40,149 | $993K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 14,408 | 3,834 | $979K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,936 | 5,788 | $933K |
| 81408 | 694 | 678 | $881K | |
| 77336 | 3,463 | 740 | $874K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 20,945 | 19,440 | $802K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,606 | 5,303 | $775K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6,829 | 6,788 | $752K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 1,149 | 1,119 | $745K |
| J9271 | Injection, pembrolizumab, 1 mg | 93 | 76 | $745K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 40,542 | 40,346 | $725K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 40,386 | 32,840 | $690K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6,926 | 6,801 | $669K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 7,308 | 6,661 | $660K |
| 86480 | 10,609 | 10,283 | $651K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 22,633 | 21,815 | $640K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8,409 | 7,975 | $628K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,333 | 1,300 | $592K |
| 80061 | Lipid panel | 50,833 | 50,035 | $568K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 3,195 | 291 | $542K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2,250 | 2,193 | $525K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 41,701 | 37,950 | $519K |
| 95808 | 803 | 799 | $489K | |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 2,424 | 2,269 | $469K |
| 71046 | Radiologic examination, chest; 2 views | 33,096 | 32,089 | $439K |
| 99441 | 13,332 | 11,807 | $422K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 56,847 | 55,607 | $420K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 14,764 | 14,641 | $419K |
| 99443 | 4,965 | 4,735 | $408K | |
| 85027 | 110,023 | 101,647 | $406K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,282 | 301 | $390K |
| 77386 | 1,725 | 184 | $387K | |
| D7140 | Extraction, erupted tooth or exposed root | 13,606 | 10,059 | $382K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,340 | 4,263 | $382K |
| 90461 | 14,948 | 14,890 | $381K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2,084 | 2,058 | $335K |
| D0330 | Panoramic radiographic image | 15,835 | 15,041 | $335K |
| 70486 | 2,139 | 2,086 | $331K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,721 | 2,606 | $328K |
| 90677 | 2,467 | 2,463 | $325K | |
| GZ3ZZZZ | 137 | 15 | $322K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8,756 | 6,702 | $320K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 36,052 | 35,364 | $319K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,544 | 3,853 | $317K |
| 86703 | 22,615 | 22,221 | $312K | |
| 86360 | 6,560 | 6,337 | $306K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 10,751 | 10,580 | $306K |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 1,214 | 1,178 | $301K |
| 86850 | 17,800 | 16,254 | $298K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2,067 | 2,007 | $291K |
| 59025 | Fetal non-stress test | 3,076 | 2,332 | $278K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 347 | 342 | $266K |
| 84443 | Thyroid stimulating hormone (TSH) | 23,093 | 22,500 | $257K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,974 | 1,038 | $255K |
| 90750 | 2,792 | 2,757 | $252K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 5,141 | 5,060 | $248K |
| D0140 | Limited oral evaluation - problem focused | 16,917 | 15,439 | $245K |
| 86359 | 6,545 | 6,323 | $245K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,487 | 4,411 | $244K |
| 76819 | Fetal biophysical profile; without non-stress testing | 3,206 | 2,910 | $232K |
| 99051 | 19,510 | 13,578 | $231K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,425 | 10,892 | $226K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,932 | 2,722 | $226K |
| 87535 | 6,363 | 6,142 | $224K | |
| 12011 | 1,034 | 992 | $222K | |
| 82948 | 44,382 | 34,337 | $219K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4,345 | 4,292 | $219K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,764 | 7,215 | $216K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,260 | 8,119 | $212K |
| 99201 | 2,173 | 2,101 | $207K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 283 | 282 | $206K |
| 77290 | 778 | 272 | $206K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 20,039 | 19,331 | $198K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8,725 | 8,457 | $196K |
| 12001 | 828 | 801 | $194K | |
| 76830 | Ultrasound, transvaginal | 2,961 | 2,835 | $194K |
| 0002A | 6,443 | 6,420 | $193K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,173 | 1,161 | $189K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 27,443 | 23,305 | $183K |
| 0001A | 6,620 | 6,602 | $181K | |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 2,150 | 613 | $180K |
| 86901 | 17,970 | 16,306 | $177K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2,226 | 2,201 | $173K |
| 76818 | 1,739 | 1,025 | $172K | |
| 76770 | 1,303 | 1,275 | $170K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,445 | 2,464 | $169K |
| 90715 | 8,030 | 7,969 | $169K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 880 | 864 | $169K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 674 | 665 | $156K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 295 | 214 | $153K |
| 81329 | 1,277 | 1,231 | $150K | |
| 86803 | 14,728 | 14,454 | $149K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,076 | 1,924 | $149K |
| 76641 | 1,168 | 1,018 | $147K | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 2,523 | 1,815 | $144K |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 4,334 | 4,079 | $144K |
| 86900 | 17,954 | 16,290 | $142K | |
| 83655 | 13,722 | 13,549 | $140K | |
| 99401 | 2,296 | 2,241 | $139K | |
| 97162 | 1,374 | 1,365 | $135K | |
| 10060 | 720 | 663 | $132K | |
| 73610 | 6,367 | 5,555 | $132K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 836 | 831 | $131K |
| 81161 | 670 | 653 | $128K | |
| 90686 | 12,980 | 12,897 | $127K | |
| 95807 | 282 | 282 | $121K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4,408 | 4,293 | $119K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 904 | 852 | $118K |
| 90697 | 1,987 | 1,986 | $118K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,945 | 2,875 | $114K |
| 81405 | 596 | 583 | $111K | |
| 77065 | Tomosynthesis, mammo | 951 | 874 | $111K |
| 29580 | 1,433 | 415 | $107K | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 1,686 | 628 | $107K |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 263 | 166 | $103K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,365 | 9,236 | $102K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,991 | 1,913 | $101K |
| 73630 | 5,165 | 4,732 | $100K | |
| 92133 | 2,228 | 2,164 | $99K | |
| 82805 | 11,013 | 9,971 | $98K | |
| 90651 | 1,997 | 1,992 | $97K | |
| 73564 | 3,711 | 3,561 | $97K | |
| 77066 | Tomosynthesis, mammo | 600 | 597 | $96K |
| 87340 | 13,385 | 13,050 | $96K | |
| 73130 | 5,051 | 4,326 | $96K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 2,606 | 2,389 | $95K |
| 11900 | 637 | 625 | $95K | |
| 97802 | 2,037 | 2,024 | $95K | |
| 0004A | 2,535 | 2,525 | $94K | |
| 90732 | 902 | 873 | $92K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1,372 | 1,159 | $92K |
| 81001 | 43,628 | 39,597 | $90K | |
| 99381 | 2,940 | 2,901 | $86K | |
| 76536 | 911 | 891 | $86K | |
| 71250 | 420 | 415 | $86K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 633 | 627 | $85K |
| 81361 | 743 | 726 | $85K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,494 | 2,435 | $85K |
| 86780 | 7,977 | 7,451 | $84K | |
| 73110 | 4,307 | 3,601 | $84K | |
| 86003 | 1,631 | 1,416 | $81K | |
| 73030 | 4,218 | 3,791 | $80K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,515 | 1,429 | $78K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 209 | 206 | $78K |
| 86706 | 10,238 | 9,985 | $78K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 142 | 141 | $77K |
| 82728 | 7,213 | 7,114 | $76K | |
| 77412 | 390 | 51 | $76K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 973 | 784 | $76K |
| 86769 | 2,631 | 2,546 | $75K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 8,218 | 8,098 | $75K |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | 404 | 392 | $73K |
| 76801 | 607 | 587 | $73K | |
| 84153 | 4,737 | 4,641 | $73K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 4,827 | 4,408 | $72K |
| 96127 | 25,204 | 23,806 | $71K | |
| 84439 | 10,242 | 9,955 | $71K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 380 | 66 | $70K |
| 20610 | 555 | 520 | $69K | |
| 93970 | 303 | 301 | $69K | |
| 12002 | 295 | 281 | $68K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | 1,772 | 1,486 | $68K |
| 92523 | 293 | 292 | $66K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,611 | 6,363 | $66K |
| 90734 | 1,636 | 1,630 | $66K | |
| 92557 | 1,455 | 1,344 | $65K | |
| 77062 | 407 | 405 | $64K | |
| 72100 | 2,227 | 2,173 | $64K | |
| 85610 | 20,696 | 18,321 | $64K | |
| 83880 | 4,528 | 4,375 | $64K | |
| 90670 | 4,151 | 4,133 | $63K | |
| 90836 | 638 | 423 | $63K | |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 63 | 63 | $62K |
| 81243 | 1,417 | 1,333 | $62K | |
| 96567 | 102 | 32 | $61K | |
| 73590 | 3,727 | 3,393 | $61K | |
| 81401 | 691 | 675 | $60K | |
| D0120 | Periodic oral evaluation - established patient | 6,483 | 6,109 | $60K |
| 93247 | 298 | 297 | $60K | |
| 94060 | 828 | 727 | $59K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 1,089 | 1,022 | $59K |
| 71045 | Radiologic examination, chest; single view | 7,023 | 6,425 | $58K |
| 77061 | 423 | 420 | $57K | |
| 93971 | 993 | 971 | $56K | |
| 84702 | 12,409 | 11,210 | $55K | |
| 88142 | 2,429 | 2,317 | $55K | |
| 83970 | 1,712 | 1,673 | $55K | |
| 83020 | 4,411 | 4,287 | $55K | |
| H0038 | Self-help/peer services, per 15 minutes | 2,005 | 1,639 | $55K |
| H2001 | Rehabilitation program, per 1/2 day | 498 | 109 | $54K |
| 76813 | 772 | 744 | $53K | |
| 90746 | 936 | 930 | $52K | |
| 86704 | 6,483 | 6,349 | $52K | |
| 73562 | 2,528 | 2,224 | $52K | |
| 73560 | 1,874 | 1,591 | $51K | |
| 87522 | Neg quan hep c or qual rna | 1,218 | 1,198 | $49K |
| 99384 | 636 | 631 | $49K | |
| H2010 | Comprehensive medication services, per 15 minutes | 746 | 685 | $49K |
| 76642 | 560 | 552 | $49K | |
| 83550 | 8,084 | 7,972 | $48K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,757 | 12,017 | $48K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 38 | 27 | $48K |
| 96367 | 1,745 | 1,403 | $48K | |
| 81257 | 716 | 699 | $48K | |
| 81025 | 12,641 | 12,130 | $47K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 169 | 103 | $46K |
| 73502 | 1,884 | 1,762 | $46K | |
| 92567 | 1,795 | 1,782 | $46K | |
| 99402 | 621 | 608 | $45K | |
| 99383 | 592 | 585 | $45K | |
| H2011 | Crisis intervention service, per 15 minutes | 236 | 196 | $44K |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,238 | 1,197 | $44K |
| 73140 | 2,095 | 1,877 | $44K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 238 | 236 | $43K |
| 94726 | 644 | 641 | $43K | |
| 86762 | 3,397 | 3,289 | $43K | |
| 92134 | 889 | 850 | $42K | |
| 87631 | 998 | 989 | $42K | |
| H0001 | Alcohol and/or drug assessment | 216 | 194 | $40K |
| 86765 | 3,400 | 3,283 | $39K | |
| 82607 | 3,334 | 3,267 | $39K | |
| 76870 | 548 | 535 | $38K | |
| 83540 | 8,199 | 8,079 | $38K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 192 | 189 | $38K |
| 84703 | 11,467 | 11,137 | $38K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 153 | 94 | $37K |
| 97161 | 480 | 471 | $37K | |
| 0072A | 935 | 934 | $36K | |
| 90620 | 1,297 | 1,276 | $36K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,163 | 1,052 | $36K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 164 | 163 | $36K |
| D1120 | Prophylaxis - child | 4,539 | 4,529 | $35K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 390 | 383 | $35K |
| 80076 | 5,948 | 5,866 | $35K | |
| 86593 | 10,507 | 10,275 | $34K | |
| D1110 | Prophylaxis - adult | 2,672 | 2,667 | $34K |
| 86787 | 3,319 | 3,208 | $34K | |
| 86735 | 3,177 | 3,077 | $34K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 51 | 51 | $34K |
| 0071A | 972 | 970 | $34K | |
| D7240 | Removal of impacted tooth - completely bony | 346 | 174 | $33K |
| 97165 | 323 | 322 | $32K | |
| 85730 | 14,234 | 13,693 | $32K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 80 | 80 | $32K |
| 77263 | 110 | 31 | $32K | |
| 86141 | 4,118 | 3,971 | $31K | |
| 92083 | 569 | 480 | $30K | |
| 96137 | 448 | 347 | $30K | |
| 86708 | 3,851 | 3,771 | $30K | |
| 95816 | 81 | 81 | $29K | |
| 90674 | 1,714 | 1,703 | $29K | |
| 73552 | 1,664 | 1,549 | $29K | |
| 87536 | 305 | 297 | $29K | |
| 97803 | 758 | 755 | $29K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 49 | 48 | $28K |
| 81400 | 688 | 672 | $28K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 469 | 451 | $28K |
| 82274 | 2,341 | 2,328 | $28K | |
| 91320 | 550 | 549 | $28K | |
| 81255 | 704 | 687 | $28K | |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | 1,204 | 834 | $27K |
| 93975 | 112 | 112 | $27K | |
| 70498 | 109 | 108 | $27K | |
| 94729 | 467 | 465 | $27K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,373 | 1,361 | $27K |
| 82043 | 5,719 | 5,594 | $27K | |
| 99382 | 347 | 347 | $27K | |
| 73090 | 2,161 | 1,951 | $26K | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,667 | 436 | $26K |
| 81251 | 705 | 688 | $25K | |
| 81200 | 703 | 686 | $25K | |
| 82951 | 2,100 | 1,980 | $25K | |
| 92250 | 667 | 640 | $25K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 2,465 | 2,290 | $24K |
| 73620 | 796 | 745 | $24K | |
| 82105 | 1,773 | 1,713 | $24K | |
| 86709 | 3,443 | 3,366 | $24K | |
| D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | 552 | 548 | $23K |
| 0124A | 565 | 564 | $23K | |
| 92579 | 417 | 416 | $23K | |
| 76000 | 221 | 219 | $23K | |
| 99245 | 126 | 126 | $22K | |
| 72070 | 679 | 671 | $22K | |
| 59425 | 740 | 667 | $22K | |
| 80320 | 6,822 | 6,527 | $22K | |
| 73080 | 1,442 | 1,271 | $21K | |
| 81260 | 702 | 686 | $21K | |
| 90480 | 636 | 635 | $21K | |
| 90716 | 1,831 | 1,825 | $21K | |
| 90707 | 1,698 | 1,692 | $21K | |
| 90633 | 2,525 | 2,517 | $20K | |
| H0049 | Alcohol and/or drug screening | 387 | 363 | $20K |
| 97166 | 204 | 204 | $20K | |
| 84146 | 1,082 | 1,045 | $19K | |
| 36430 | 93 | 82 | $19K | |
| 97010 | 2,838 | 1,525 | $19K | |
| 93308 | 258 | 251 | $19K | |
| 73700 | 88 | 80 | $19K | |
| 82785 | 1,324 | 1,298 | $19K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 183 | 172 | $19K |
| 96161 | 3,215 | 3,055 | $19K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 7,360 | 7,104 | $18K |
| 84403 | 724 | 662 | $18K | |
| 0011A | 1,243 | 1,232 | $18K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 204 | 120 | $18K |
| D9222 | 820 | 809 | $18K | |
| 87486 | 853 | 847 | $18K | |
| 86580 | 3,331 | 3,246 | $17K | |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 13 | 12 | $17K |
| 71271 | 84 | 83 | $17K | |
| 90681 | 2,349 | 2,345 | $17K | |
| 83001 | 939 | 893 | $17K | |
| 92555 | 375 | 374 | $17K | |
| 93017 | 279 | 276 | $16K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 562 | 349 | $16K |
| D0274 | Bitewings - four radiographic images | 2,760 | 2,747 | $16K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 560 | 557 | $16K |
| 85007 | 7,045 | 6,619 | $15K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 615 | 533 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,815 | 5,494 | $15K |
| 86160 | 940 | 813 | $15K | |
| 81003 | 5,618 | 4,725 | $15K | |
| 99385 | 208 | 204 | $15K | |
| 90656 | 1,254 | 1,254 | $14K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2,172 | 2,054 | $14K |
| 77080 | 503 | 495 | $14K | |
| 84484 | 10,875 | 9,678 | $14K | |
| D7230 | 207 | 148 | $14K | |
| 85045 | 4,901 | 4,672 | $14K | |
| 73060 | 1,198 | 1,097 | $14K | |
| 87581 | 853 | 847 | $14K | |
| 83735 | 7,426 | 6,969 | $14K | |
| 92002 | 168 | 163 | $14K | |
| 99408 | 289 | 216 | $14K | |
| 83002 | 779 | 737 | $14K | |
| 87081 | 2,957 | 2,903 | $14K | |
| 90698 | 2,105 | 2,103 | $14K | |
| 90694 | 539 | 536 | $14K | |
| 96158 | 239 | 179 | $14K | |
| D1208 | Topical application of fluoride, excluding varnish | 3,597 | 3,589 | $13K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 13 | 12 | $13K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 68 | 64 | $13K |
| 76820 | 303 | 148 | $13K | |
| 80165 | 1,453 | 1,404 | $13K | |
| 36416 | 658 | 629 | $12K | |
| 86592 | 3,896 | 3,575 | $12K | |
| 84207 | 448 | 446 | $12K | |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 227 | 89 | $12K |
| 93246 | 293 | 291 | $12K | |
| 83615 | 3,036 | 2,894 | $11K | |
| D1206 | Topical application of fluoride varnish | 2,520 | 2,516 | $11K |
| 96040 | 189 | 179 | $11K | |
| 82570 | 2,953 | 2,825 | $11K | |
| 72170 | 724 | 702 | $11K | |
| D0220 | Intraoral - periapical first radiographic image | 2,978 | 2,954 | $11K |
| 86008 | 110 | 91 | $11K | |
| 59430 | 50 | 50 | $11K | |
| 87186 | 3,168 | 3,052 | $11K | |
| 82947 | 1,572 | 1,352 | $11K | |
| 72190 | 613 | 603 | $11K | |
| 72141 | 25 | 24 | $11K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 10,956 | 8,891 | $10K |
| 84100 | 5,967 | 5,677 | $10K | |
| 52000 | 12 | 12 | $10K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 13 | 13 | $10K |
| 99412 | 183 | 55 | $10K | |
| 54161 | 14 | 13 | $9K | |
| 85651 | 3,669 | 3,545 | $9K | |
| 31575 | 75 | 74 | $9K | |
| 92015 | Determination of refractive state | 427 | 422 | $9K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 29 | 25 | $9K |
| Q3014 | Telehealth originating site facility fee | 1,243 | 1,031 | $9K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,425 | 1,184 | $9K |
| 77334 | 50 | 40 | $9K | |
| 93976 | 59 | 59 | $9K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 9,353 | 8,578 | $9K |
| 87538 | 258 | 253 | $8K | |
| 93320 | 160 | 159 | $8K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 14 | 14 | $8K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 172 | 170 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | 12,037 | 11,305 | $8K |
| D9995 | 341 | 317 | $8K | |
| 86225 | 829 | 807 | $8K | |
| 73070 | 715 | 655 | $8K | |
| 90648 | 1,386 | 1,382 | $8K | |
| 73120 | 371 | 335 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,388 | 17,115 | $8K |
| 0081A | 178 | 178 | $8K | |
| 90744 | 951 | 950 | $8K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 356 | 353 | $8K |
| 86038 | 921 | 907 | $8K | |
| J2704 | Injection, propofol, 10 mg | 4,382 | 4,132 | $8K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 41 | 38 | $8K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 486 | 463 | $7K |
| 90653 | 278 | 278 | $7K | |
| 70491 | 25 | 24 | $7K | |
| 83516 | 542 | 508 | $7K | |
| 31231 | 36 | 36 | $7K | |
| 96415 | 33 | 24 | $7K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 454 | 358 | $7K |
| 70496 | 39 | 38 | $7K | |
| 84425 | 393 | 388 | $7K | |
| 90661 | 538 | 538 | $7K | |
| 84156 | 2,336 | 2,219 | $7K | |
| 92551 | 5,216 | 5,214 | $7K | |
| 87088 | 912 | 886 | $7K | |
| 84436 | 1,680 | 1,636 | $7K | |
| 77300 | 62 | 60 | $6K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 3,373 | 2,976 | $6K |
| 84445 | 138 | 133 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 235 | 234 | $6K |
| 93325 | 210 | 206 | $6K | |
| 86376 | 457 | 449 | $6K | |
| 82803 | 2,326 | 2,085 | $6K | |
| 90723 | 998 | 994 | $6K | |
| 76814 | 283 | 267 | $6K | |
| H0033 | Oral medication administration, direct observation | 140 | 112 | $6K |
| 85018 | 2,372 | 2,371 | $6K | |
| D9239 | 179 | 176 | $6K | |
| 0012A | 278 | 278 | $6K | |
| G0390 | Trauma response team associated with hospital critical care service | 127 | 125 | $6K |
| 96900 | 202 | 66 | $5K | |
| 83690 | 7,988 | 7,494 | $5K | |
| 73600 | 278 | 261 | $5K | |
| 86235 | 132 | 113 | $5K | |
| 0082A | 117 | 117 | $5K | |
| 84134 | 459 | 454 | $5K | |
| D0272 | Bitewings - two radiographic images | 1,910 | 1,904 | $5K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 60 | 12 | $5K |
| 87338 | 452 | 450 | $5K | |
| 97168 | 71 | 69 | $5K | |
| 67228 | 15 | 12 | $5K | |
| 92558 | 269 | 268 | $5K | |
| 88304 | 167 | 163 | $5K | |
| 87800 | 193 | 193 | $5K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 50 | 50 | $5K |
| 87070 | 1,337 | 1,248 | $5K | |
| 87517 | 102 | 100 | $5K | |
| 72197 | 12 | 12 | $4K | |
| 77427 | 22 | 12 | $4K | |
| 99406 | 405 | 391 | $4K | |
| 96910 | 41 | 13 | $4K | |
| 96376 | 2,068 | 1,898 | $4K | |
| 92504 | 110 | 106 | $4K | |
| 90736 | 32 | 32 | $4K | |
| D0603 | 1,319 | 1,241 | $4K | |
| 99386 | 39 | 39 | $4K | |
| 97116 | 151 | 83 | $4K | |
| 99173 | 4,791 | 4,789 | $4K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 67 | 62 | $4K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,057 | 1,920 | $4K |
| 82652 | 102 | 99 | $4K | |
| 72131 | 26 | 26 | $4K | |
| 84590 | 345 | 342 | $4K | |
| 82248 | 1,016 | 925 | $4K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 14 | 14 | $4K |
| 82784 | 235 | 154 | $4K | |
| 96368 | 326 | 283 | $3K | |
| 87390 | 507 | 501 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,514 | 5,065 | $3K |
| 96380 | 200 | 200 | $3K | |
| 90696 | 516 | 516 | $3K | |
| 83021 | 527 | 527 | $3K | |
| J1741 | Injection, ibuprofen, 100 mg | 917 | 915 | $3K |
| D9243 | 64 | 64 | $3K | |
| 84235 | 54 | 53 | $3K | |
| 96136 | 39 | 38 | $3K | |
| 96156 | 36 | 36 | $3K | |
| 84550 | 1,185 | 1,096 | $3K | |
| 90710 | 333 | 333 | $3K | |
| 82670 | 117 | 110 | $3K | |
| 82550 | 1,597 | 1,533 | $3K | |
| 86689 | 505 | 499 | $3K | |
| 93351 | 13 | 13 | $3K | |
| 74019 | 121 | 119 | $3K | |
| 86696 | 221 | 208 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,847 | 5,636 | $3K |
| 87205 | 1,630 | 1,450 | $3K | |
| 41800 | 27 | 24 | $3K | |
| 0074A | 71 | 71 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,587 | 7,630 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 662 | 649 | $3K |
| 96402 | 75 | 74 | $3K | |
| 82677 | 112 | 111 | $3K | |
| D9430 | 199 | 162 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,668 | 3,758 | $3K |
| 86334 | 147 | 119 | $2K | |
| 90739 | 17 | 17 | $2K | |
| 72040 | 82 | 82 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,944 | 3,548 | $2K |
| 86695 | 223 | 209 | $2K | |
| D2740 | Crown - porcelain/ceramic | 33 | 28 | $2K |
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 17 | 12 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,566 | 3,337 | $2K |
| 87071 | 609 | 604 | $2K | |
| 80178 | 348 | 324 | $2K | |
| 74018 | 97 | 94 | $2K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | 12 | $2K |
| 82977 | 448 | 431 | $2K | |
| 1159F | 16,360 | 9,690 | $2K | |
| 83605 | 1,163 | 1,108 | $2K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 2,786 | 2,603 | $2K |
| D9110 | 223 | 213 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 708 | 406 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,955 | 1,863 | $2K |
| 84402 | 85 | 83 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,749 | 1,316 | $2K |
| 83883 | 126 | 68 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,442 | 6,170 | $2K |
| 85379 | 1,311 | 1,296 | $2K | |
| 90717 | 13 | 13 | $2K | |
| 86140 | 621 | 594 | $2K | |
| 76885 | 13 | 13 | $2K | |
| 82375 | 698 | 667 | $2K | |
| 74246 | 12 | 12 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 59 | 58 | $2K |
| 99242 | 43 | 39 | $2K | |
| D0230 | Intraoral - periapical each additional radiographic image | 652 | 650 | $2K |
| 12013 | 13 | 13 | $2K | |
| 82010 | 1,882 | 1,644 | $2K | |
| 90700 | 219 | 218 | $2K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 9,151 | 7,771 | $2K |
| 73000 | 92 | 88 | $2K | |
| 82330 | 1,130 | 1,081 | $2K | |
| 86923 | 77 | 67 | $2K | |
| 72128 | 13 | 13 | $2K | |
| 84165 | 212 | 160 | $2K | |
| 70360 | 86 | 83 | $2K | |
| 99429 | 125 | 109 | $2K | |
| 74022 | 99 | 98 | $2K | |
| 87184 | 270 | 268 | $2K | |
| 86336 | 111 | 110 | $1K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 370 | 312 | $1K |
| 82810 | 698 | 667 | $1K | |
| 71100 | 152 | 142 | $1K | |
| 82746 | 144 | 139 | $1K | |
| J1815 | Injection, insulin, per 5 units | 1,867 | 1,321 | $1K |
| 96160 | 150 | 143 | $1K | |
| 11721 | 32 | 29 | $1K | |
| 87521 | Neg quan hep c or qual rna | 44 | 42 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,641 | 2,077 | $1K |
| 84480 | 138 | 131 | $1K | |
| 58300 | 12 | 12 | $1K | |
| 92235 | 12 | 12 | $1K | |
| 85384 | 495 | 420 | $1K | |
| 90691 | 15 | 15 | $1K | |
| 72081 | 29 | 29 | $1K | |
| 82962 | 1,116 | 1,045 | $1K | |
| 71048 | 72 | 71 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 458 | 434 | $1K |
| 76775 | 75 | 63 | $1K | |
| 86800 | 81 | 79 | $1K | |
| 0154A | 35 | 35 | $1K | |
| 86255 | 143 | 137 | $1K | |
| 80354 | 2,251 | 1,930 | $1K | |
| 86320 | 42 | 38 | $1K | |
| 73660 | 94 | 89 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | 12 | 12 | $1K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 621 | 426 | $1K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,121 | 1,115 | $1K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 3,261 | 2,990 | $1K |
| 90662 | 60 | 60 | $1K | |
| 3075F | 19,590 | 17,427 | $1K | |
| 87040 | 488 | 438 | $1K | |
| 84704 | 67 | 66 | $962.70 | |
| 82247 | 200 | 165 | $948.01 | |
| 86430 | 188 | 184 | $909.69 | |
| 94760 | 1,459 | 1,421 | $903.50 | |
| 80348 | 87 | 70 | $886.87 | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,776 | 2,408 | $878.82 |
| 88312 | 13 | 13 | $855.04 | |
| 0502F | 203 | 166 | $849.74 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,022 | 2,778 | $803.50 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 6,838 | 6,004 | $788.66 |
| 76857 | 12 | 12 | $786.36 | |
| D0170 | 121 | 113 | $757.56 | |
| D1351 | Sealant - per tooth | 81 | 29 | $750.75 |
| 87593 | 20 | 19 | $744.36 | |
| D0210 | Intraoral - complete series of radiographic images | 91 | 91 | $740.42 |
| 83050 | 698 | 667 | $739.84 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 628 | 608 | $734.65 |
| 98960 | 22 | 20 | $728.15 | |
| 82952 | 163 | 156 | $725.88 | |
| 82627 | 33 | 29 | $695.10 | |
| 80164 | 69 | 68 | $676.46 | |
| S0190 | Mifepristone, oral, 200 mg | 12 | 12 | $667.56 |
| 73100 | 26 | 26 | $626.84 | |
| 82533 | 39 | 37 | $607.19 | |
| 90713 | 54 | 54 | $603.66 | |
| J2060 | Injection, lorazepam, 2 mg | 1,985 | 1,767 | $589.12 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 250 | 244 | $582.00 |
| 86705 | 74 | 69 | $537.83 | |
| 0003A | 13 | 13 | $520.80 | |
| 0031A | 12 | 12 | $519.91 | |
| 88300 | 49 | 48 | $517.54 | |
| 82950 | 93 | 93 | $515.91 | |
| D3330 | Endodontic therapy, molar tooth (excluding final restoration) | 13 | 13 | $514.50 |
| 99451 | 14 | 14 | $511.68 | |
| 84479 | 121 | 121 | $509.16 | |
| J3411 | Injection, thiamine hcl, 100 mg | 660 | 607 | $464.08 |
| 94761 | 683 | 668 | $442.63 | |
| 74021 | 17 | 17 | $434.79 | |
| J9035 | Injection, bevacizumab, 10 mg | 16 | 12 | $417.15 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 464 | 460 | $407.05 |
| 81015 | 172 | 164 | $393.93 | |
| 82164 | 27 | 24 | $392.22 | |
| 82955 | 41 | 41 | $387.03 | |
| 73521 | 13 | 13 | $382.04 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 13 | 13 | $358.36 |
| 95851 | 14 | 14 | $350.65 | |
| 83498 | 14 | 13 | $350.52 | |
| V2632 | Posterior chamber intraocular lens | 27 | 27 | $349.47 |
| D9990 | 30 | 27 | $341.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 132 | 123 | $338.23 |
| J1170 | Injection, hydromorphone, up to 4 mg | 222 | 186 | $333.27 |
| 85041 | 298 | 298 | $325.93 | |
| 82042 | 15 | 15 | $325.69 | |
| 51798 | 13 | 12 | $295.89 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 2,003 | 1,781 | $289.38 |
| 82397 | 67 | 66 | $280.93 | |
| 90381 | 51 | 51 | $278.99 | |
| 85652 | 159 | 155 | $276.90 | |
| 85060 | 14 | 14 | $254.82 | |
| 11720 | 14 | 12 | $253.95 | |
| 90611 | 224 | 223 | $251.81 | |
| 85014 | 299 | 299 | $242.29 | |
| 83010 | 39 | 37 | $232.92 | |
| 80329 | 51 | 49 | $225.48 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 110 | 108 | $211.10 |
| 85240 | 13 | 12 | $204.52 | |
| D0270 | 52 | 51 | $198.88 | |
| 87147 | 37 | 37 | $195.20 | |
| D9310 | 53 | 53 | $194.50 | |
| D0602 | 234 | 231 | $192.47 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 26 | 25 | $173.12 |
| J1756 | Injection, iron sucrose, 1 mg | 41 | 12 | $171.42 |
| 90685 | 204 | 204 | $169.15 | |
| D0601 | 435 | 431 | $157.86 | |
| 84520 | 115 | 100 | $141.52 | |
| 84154 | 12 | 12 | $134.25 | |
| 84155 | 34 | 33 | $123.95 | |
| D0190 | 824 | 821 | $97.57 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 43 | 39 | $96.32 |
| G0008 | Administration of influenza virus vaccine | 227 | 227 | $92.96 |
| 87899 | 25 | 14 | $87.11 | |
| 82565 | 46 | 46 | $81.31 | |
| D9219 | 22 | 20 | $77.54 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 81 | 66 | $72.40 |
| 84132 | 42 | 42 | $60.28 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 17 | 16 | $59.87 |
| 82465 | 14 | 12 | $58.27 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 42 | 39 | $56.43 |
| 81002 | 21 | 21 | $56.16 | |
| 82310 | 14 | 14 | $50.99 | |
| 90380 | 12 | 12 | $50.20 | |
| S0028 | Injection, famotidine, 20 mg | 92 | 90 | $49.11 |
| 82435 | 39 | 39 | $46.40 | |
| D9420 | 33 | 30 | $45.74 | |
| 84295 | 39 | 39 | $41.82 | |
| 82150 | 33 | 33 | $38.56 | |
| 87210 | 13 | 13 | $35.89 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 49 | 49 | $28.54 |
| 3078F | 62,006 | 48,759 | $28.07 | |
| 87075 | 29 | 28 | $19.89 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 26 | 24 | $16.51 |
| J1940 | Injection, furosemide, up to 20 mg | 19 | 12 | $14.53 |
| 88720 | 160 | 145 | $11.97 | |
| 3074F | 53,499 | 42,652 | $8.49 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 43 | 43 | $8.21 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 14 | 14 | $8.02 |
| 3079F | 20,669 | 17,881 | $7.78 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 31 | 31 | $3.75 |
| J3480 | Injection, potassium chloride, per 2 meq | 16 | 13 | $3.50 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 14 | 12 | $1.71 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 26 | 26 | $1.04 |
| 3077F | 16,149 | 12,791 | $0.53 | |
| 1160F | 11,295 | 8,153 | $0.30 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 25 | 25 | $0.08 |
| D1330 | 818 | 818 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 26 | 26 | $0.00 |
| 3080F | 6,081 | 5,124 | $0.00 | |
| 3044F | 154 | 154 | $0.00 | |
| 1220F | 1,455 | 1,454 | $0.00 | |
| 80050 | General health panel | 479 | 478 | $0.00 |
| 44388 | 35 | 35 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 12 | 12 | $0.00 |
| 71020 | 27 | 26 | $0.00 | |
| D1310 | 90 | 90 | $0.00 | |
| 99080 | 4,150 | 935 | $0.00 | |
| 99499 | 5,546 | 4,132 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 212 | 203 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 50 | 50 | $0.00 |
| 48510 | 14 | 14 | $0.00 | |
| 3725F | 15 | 15 | $0.00 | |
| 2022F | 28 | 28 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 56 | 56 | $0.00 |